[P25-5] P25-5: Anti-infective drugs (5)

[P25-5-1] Development of an immunoassay-based point-of-care testing (POCT) device for therapeutic drug monitoring of vancomycin

Koichiro Tsuchiya¹, Takeyoshi Abe², Masahiro Watanabe³, Toshiki Takeuchi⁴, Noriyasu Fukuoka⁵, Yasuko Tomono⁶, Akari Katsura⁷, Hideki Watanabe⁸, Takayuki Kamada⁹, Kazunori Abe¹⁰, Katsunori Tsuda¹¹, Licht Miyamoto¹² (1.Tokushima University, 2.Japan Community Health Care Organization Ritsurin Hospital, 3.School of Pharmacy, Shujitsu University, 4.Tokushima University, 5.School of Pharmacy, Nihon University, 6.Shigei Medical Research Institute, 7.Tokushima University, 8.Furukawa Electric Advanced Engineering Co., Ltd., 9.Furukawa Electric Advanced Engineering Co., Ltd., 10.Japan Biotechno Pharma Co., Ltd., 11.Tokushima University, 12.Tokushima University)

Keywords:POCT, vancomycin, TDM, fluorescent silica nanoparticles, immunochromatography